Question Everything. See who's reporting it.

Ozempic Causes Blindness? Patients Sue GLP-1 Drugmakers Over Rare Eye Condition Risk

Source: Free Press Journal

The story in brief

Patients are suing drugmakers over alleged rare eye condition risk linked to GLP-1 medicines. The legal claims involve Ozempic, Wegovy, and Zepbound, with the condition being nonarteritic anterior ischemic optic neuropathy (NAION). The potential connection remains under investigation, and Eli Lilly has disputed the claims.

2 outletsSee what the other 1 outlet said

NEWXFree on Android and iPhone. Open in NEWX